Delving into the Latest Updates on Shenyang Xintager Pharmaceutical Technology Development Co., Ltd. with Synapse

Overview

本试验的目的是探索淋巴示踪用盐酸米托蒽醌注射液对胃癌患者淋巴示踪的有效性、安全性和耐受性并确定试验用药物最优使用剂量范围，同时探索淋巴示踪用盐酸米托蒽醌注射液对胃癌患者的药代动力学特征，为III 期临床试验的用药剂量及评价指标提供合理依据。

[Translation]

The purpose of this trial is to explore the effectiveness, safety and tolerability of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer and determine the optimal dosage range of the trial drug. At the same time, it is to explore the pharmacokinetic characteristics of mitoxantrone hydrochloride injection for lymphatic tracing in patients with gastric cancer, and to provide a reasonable basis for the dosage and evaluation indicators of the Phase III clinical trial.

Start Date01 Sep 2020

Sponsor / Collaborator

Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

[+2]

CTR20192435

/ CompletedPhase 2/3

淋巴示踪用盐酸米托蒽醌注射液用于乳腺癌手术前哨淋巴结示踪的有效性和安全性的多中心、阳性、自身对照临床

[Translation] A multicenter, positive, self-controlled clinical trial of the efficacy and safety of mitoxantrone hydrochloride injection for sentinel lymph node tracing before breast cancer surgery

评价试验药物对乳腺癌受试者前哨淋巴结示踪的有效性与安全性。

[Translation]

To evaluate the effectiveness and safety of investigational drugs in sentinel lymph node tracing in subjects with breast cancer.

Start Date11 Dec 2019

Sponsor / Collaborator

Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

[+2]

100 Clinical Results associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.

Login to view more data

100 Deals associated with Shenyang Xintager Pharmaceutical Technology Development Co., Ltd.